Ihm Eun-Hyun, Hong Chang-Ki, Shim Yu-Shik, Jung Jin-Young, Joo Jin-Yang, Park Seoung-Woo
Department of Neurosurgery, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
J Korean Neurosurg Soc. 2010 Oct;48(4):330-4. doi: 10.3340/jkns.2010.48.4.330. Epub 2010 Oct 30.
Residual aneurysm from incomplete clipping or slowly recurrent aneurysm is associated with high risk of subarachnoid hemorrhage. We describe complete treatment of the lesions by surgical clipping or endovascular treatment.
We analyzed 11 patients of residual or recurrent aneurysms who had undergone surgical clipping from 1998 to 2009. Among them, 5 cases were initially clipped at our hospital. The others were referred from other hospitals after clipping. The radiologic and medical records were retrospectively analyzed.
All patients presented with subarachnoid hemorrhage at first time, and the most frequent location of the ruptured residual or recurrent aneurysm was in the anterior communicating artery to posterior-superior direction. Distal anterior cerebral artery, posterior communicating artery, and middle cerebral artery was followed. Repositioning of clipping in eleven cases, and one endovascular treatment were performed. No residual aneurysm was found in postoperative angiography, and no complication was noted in related to the operations.
These results indicate the importance of postoperative or follow up angiography and that reoperation of residual or slowly recurrent aneurysm should be tried if such lesions being found. Precise evaluation and appropriate planning including endovascular treatment should be performed for complete obliteration of the residual or recurrent aneurysm.
不完全夹闭导致的残留动脉瘤或缓慢复发的动脉瘤与蛛网膜下腔出血的高风险相关。我们描述了通过手术夹闭或血管内治疗对这些病变进行彻底治疗的情况。
我们分析了1998年至2009年间接受手术夹闭的11例残留或复发性动脉瘤患者。其中,5例最初在我院接受夹闭治疗。其他患者在夹闭治疗后从其他医院转诊而来。对影像学和病历进行了回顾性分析。
所有患者首次均表现为蛛网膜下腔出血,残留或复发性动脉瘤破裂最常见的部位是前交通动脉向后上方向。其次是大脑前动脉远端、后交通动脉和大脑中动脉。对11例患者进行了夹闭复位,并进行了1例血管内治疗。术后血管造影未发现残留动脉瘤,且未发现与手术相关的并发症。
这些结果表明术后或随访血管造影的重要性,并且如果发现残留或缓慢复发的动脉瘤,应尝试再次手术。应为彻底消除残留或复发性动脉瘤进行精确评估和包括血管内治疗在内的适当规划。